Literature DB >> 29039077

Chronic light exposure alters serotonergic and orexinergic systems in the rat brain and reverses maternal separation-induced increase in orexin receptors in the prefrontal cortex.

J J Dimatelis1, A Mtintsilana2, V Naidoo2, D J Stein3, V A Russell2.   

Abstract

Maternal separation (MS) is a well-established rodent model of depression. Chronic constant light (CCL) treatment during adolescence has been shown to reverse the depression-like behaviour induced by MS. We aimed to further delineate the antidepressant effect of light by investigating the involvement of the dopaminergic, serotonergic and orexinergic systems. MS was used to induce changes in adult male Sprague-Dawley rats, some of whom were also treated with CCL for 3 weeks during adolescence. At P80, rats were decapitated and brain tissue collected for analysis of glutamate- and potassium-stimulated dopamine release in the nucleus accumbens (NAc) using an in vitro superfusion technique. Enzyme-linked immunosorbent assays were employed to measure 5-hydroxytryptamine (5-HT) levels in the hypothalamus and prefrontal cortex (PFC). Western blotting was used to measure orexin receptor 1 (OXR-1) and 2 (OXR-2) in the PFC. MS did not affect 5-HT levels in these rats. However, CCL increased hypothalamic 5-HT and reduced 5-HT levels in the PFC. CCL had opposite effects on OXR levels in the PFC of maternally separated and non-separated rats. MS increased OXR-1 and OXR-2 levels in the PFC, an effect that was normalized by CCL treatment. MS reduced glutamate-stimulated dopamine release in the NAc, an effect that was not reversed by CCL. The present results suggest that CCL treatment affects 5-HT and orexinergic systems in the MS model while not affecting the MS-induced decrease in dopamine release in the NAc. The reversal of changes in the orexinergic system may be of particular relevance to the antidepressant effect of CCL in depression.

Entities:  

Keywords:  Chronic constant light; Depression; Dopamine, serotonin; Maternal separation; Orexin

Mesh:

Substances:

Year:  2017        PMID: 29039077     DOI: 10.1007/s11011-017-0123-0

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  63 in total

1.  The social defeat animal model of depression shows diminished levels of orexin in mesocortical regions of the dopamine system, and of dynorphin and orexin in the hypothalamus.

Authors:  C Nocjar; J Zhang; P Feng; J Panksepp
Journal:  Neuroscience       Date:  2012-05-22       Impact factor: 3.590

2.  Neonatal exposure to constant light prevents anhedonia-like behavior induced by constant light exposure in adulthood.

Authors:  Bruno J Martynhak; Diego Correia; Lívia H Morais; Paula Araujo; Monica L Andersen; Marcelo M S Lima; Fernando M Louzada; Roberto Andreatini
Journal:  Behav Brain Res       Date:  2011-03-21       Impact factor: 3.332

3.  Orexinergic signaling mediates light-induced neuronal activation in the dorsal raphe nucleus.

Authors:  W Adidharma; G Leach; L Yan
Journal:  Neuroscience       Date:  2012-06-16       Impact factor: 3.590

Review 4.  Adolescent development, hypothalamic-pituitary-adrenal function, and programming of adult learning and memory.

Authors:  Cheryl M McCormick; Iva Z Mathews
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2009-09-25       Impact factor: 5.067

5.  Disruption of circadian rhythms due to chronic constant light leads to depressive and anxiety-like behaviors in the rat.

Authors:  Araceli Tapia-Osorio; Roberto Salgado-Delgado; Manuel Angeles-Castellanos; Carolina Escobar
Journal:  Behav Brain Res       Date:  2013-05-25       Impact factor: 3.332

Review 6.  Serotonin and depression: pathophysiological mechanism or marketing myth?

Authors:  Philip J Cowen
Journal:  Trends Pharmacol Sci       Date:  2008-09       Impact factor: 14.819

7.  Differential effect of environment enrichment and social isolation on depressive-like behavior, spontaneous activity and serotonin and norepinephrine concentration in prefrontal cortex and ventral striatum.

Authors:  Juan C Brenes; Odir Rodríguez; Jaime Fornaguera
Journal:  Pharmacol Biochem Behav       Date:  2007-11-22       Impact factor: 3.533

8.  Morning bright light therapy: a helpful tool for reducing comorbid symptoms of affective and behavioral dysregulation in juvenile depressed inpatients? A pilot trial.

Authors:  Sarah Bogen; Tanja Legenbauer; Stephanie Gest; Martin Holtmann
Journal:  Z Kinder Jugendpsychiatr Psychother       Date:  2016-06-13

9.  Prolonged maternal separation disturbs the serotonergic system during early brain development.

Authors:  Ken-Ichi Ohta; Takanori Miki; Katsuhiko Warita; Shingo Suzuki; Takashi Kusaka; Tomiko Yakura; Jun-Qian Liu; Motoki Tamai; Yoshiki Takeuchi
Journal:  Int J Dev Neurosci       Date:  2013-10-31       Impact factor: 2.457

10.  Reduced orexin levels in the cerebrospinal fluid of suicidal patients with major depressive disorder.

Authors:  Lena Brundin; Maria Björkqvist; Asa Petersén; Lil Träskman-Bendz
Journal:  Eur Neuropsychopharmacol       Date:  2007-03-07       Impact factor: 4.600

View more
  1 in total

Review 1.  Neurobiology of the Orexin System and Its Potential Role in the Regulation of Hedonic Tone.

Authors:  Martin A Katzman; Matthew P Katzman
Journal:  Brain Sci       Date:  2022-01-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.